Login or sign up: Please either login to Lexology or sign up for our free legal news service to be able to register for this event.

Antiviral patents – how prepared are we to combat novel viral diseases?

PatentSight GmbH


With the novel coronavirus spreading both fear and illness across the world, it is a worthwhile exercise to look at the patent landscape of antiviral vaccines. By analysing both the quality and quantity of the patent portfolios of the world's leading manufacturers and researchers, it is possible to evaluate the companies and research institutes that are at the forefront of finding vaccines and cures for potentially deadly viral diseases.

Join our webinar to learn more about:

  • The entire technology field and key players in the antiviral vaccine market
  • Review of selected companies who have technologies related to coronavirus
  • Portfolio landscaping of global pharma leaders in this technology field
  • How PatentSight metrics evaluate the portfolio strength



William Mansfield
Head of consulting and customer success
LexisNexis® PatentSight®




William Mansfield is the head of consulting and customer success at LexisNexis® PatentSight®. He is responsible for the creation and delivery of PatentSight’s consulting projects. He works closely with numerous international and Fortune 500 companies to ensure effective deployment of patent analyses for business strategy, M&A due diligence and portfolio management.


14 April 2020
14:00 - 14:55 UTC
55 min